Overview A Study of S6G5T 3 in the Treatment of Acne Vulgaris Status: Completed Trial end date: 2019-12-11 Target enrollment: Participant gender: Summary To assess the efficacy of S6G5T-3 compared to its Vehicle when applied once daily for 12 weeks in Patients with acne vulgaris Phase: Phase 3 Details Lead Sponsor: Sol-Gel Technologies, Ltd.